One year in review 2019: idiopathic inflammatory myopathies

Alessandra Tripoli, Emiliano Marasco, Laura Cometi, Ludovico De Stefano, Elisa Marcucci, Federica Furini, Simone Barsotti, Lorenzo Cavagna

Research output: Contribution to journalReview articlepeer-review


The idiopathic inflammatory myopathies (IIMs) are a rare group of immune, systemic diseases characterised by muscle inflammation and frequently by extramuscular involvement. IIMs are heterogeneous with generally a chronic or subacute onset, which vary from less severe to more serious manifestations, not always easy to diagnose and even less to manage. In the past year, many studies have been published in order to clarify disease pathogenesis and improve patient management and treatment.The purpose of this review article is to provide an overview of the new insights in pathogenesis, serological findings, clinical manifestations and treatment of IIMs, summarising the most relevant studies published over the last year.

Original languageEnglish
Pages (from-to)1-10
Number of pages10
JournalClinical and Experimental Rheumatology
Issue number1
Publication statusPublished - Jan 1 2020

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'One year in review 2019: idiopathic inflammatory myopathies'. Together they form a unique fingerprint.

Cite this